Senseonics Holdings Inc

NYSE American:SENSUnited States

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.

Contact Information

Headquarters

20451 Seneca Meadows PkwyGERMANTOWN, MD, United States 20876-7005

Phone

301-515-7260

Fax

302-655-5049

Executives

Independent Chairman of the Board

Stephen Defalco

President, Chief Executive Officer, Director

Timothy Goodnow

Chief Financial Officer, Treasurer, Secretary

Frederick Sullivan

Chief Operating Officer

Mukul Jain

General Counsel, Corporate Development Advisor

Kenneth Horton